Not Yet RecruitingNCT07144072
Safety and Tolerability Study of Mesenchymal Stem Cells, HeXell-2020, in Elderly Subjects With Mild to Moderate Frailty Syndrome
PHASE1 · 12 planned enrolment
- Countries listed
- 0
- Registry update
- September 25, 2026
Program Identity
HeXell-2020-FS-001
Exact source-linked program identifier and related public trial registrations.
Hexun Biosciences Co., LTD.
HeXell-2020-FS-001
1 exact source-linked registration. No aliases, synonyms, ownership, or cross-source equivalence are inferred.